Hutch News

Stories tagged 'Transplant and Immunotherapy'

What we can learn about global flu evolution from individual infections

Study of 10-year-old flu samples finds virus’s evolution in individual transplant patients partially mirrors later global trends

June 27, 2017 | By Rachel Tompa / Fred Hutch News Service

When it comes to the flu, a few infected people may speak for the multitude. Evolutionary biologists have found that evolution in individual infections has parallels to the virus's later global evolution.

View story >


A boy, his chicken and a bone marrow transplant

An experimental treatment — and an unconventional pet — offered both hope and healing for Andrew Adams’ rare and debilitating genetic disorder

June 23, 2017 | By Rachel Tompa / Fred Hutch News Service

It took a team of clinicians and years to get Andrew Adams to the other side of his life-threatening symptoms. Throughout it all, his beloved pet chicken Frightful kept his spirits up.

View story >


Good News at Fred Hutch

Celebrating faculty and staff achievements

June 22, 2017

A new algorithm created by Dr. Philip Bradley and colleagues could aid the development of tools to decode T-cell receptor sequences and, ultimately, improve the diagnosis and treatment of cancers, reported this week in Nature.

View story >


Forum at Fred Hutch focuses on the hottest developments in cancer immunotherapy

Immune-based treatments move from the fringes to the spotlight

June 16, 2017 | By Susan Keown / Fred Hutch News Service

What's new in cancer immunotherapy? Five hot topics, from new combination therapies to cost.

View story >


Scared — and brave

Why volunteer for an HIV cure study? A community group undertakes its own research to find out

June 14, 2017 | By Mary Engel / Fred Hutch News Service

People who volunteer for HIV cure studies “want to feel like they’re contributing to the greater body of knowledge,” according to a community-led study. “But they want to feel like they can trust [the researchers], like they’re being treated with respect.”

View story >


Using a virus to teach the immune system to kill cancer

‘Exciting’ results from early trial spurs further development of novel vaccine for sarcoma

June 2, 2017 | By Susan Keown / Fred Hutch News Service

This cancer vaccine uses a virus to teach sarcoma patients’ immune systems to kill tumor cells. It was tested in an early-stage clinical trial.

View story >



GIVE NOW &
SAVE LIVES

Support our quest for cures

Story Archive


Publications

Hutch Magazine
Our quarterly magazine

Annual Report
Fiscal year highlights

Science Spotlight
Monthly review of Center-authored papers



Fred Hutch News

        Get updates via email.